Jian-Yong Li
Jiangsu Province Hospital(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research
Most-Cited Works
- → Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)(2021)60 cited
- → MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma(2015)56 cited
- → TP53 dysfunction in diffuse large B-cell lymphoma(2015)55 cited
- → Identify truly high-risk TP53-mutated diffuse large B cell lymphoma patients and explore the underlying biological mechanisms(2024)13 cited
- → Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China(2016)7 cited
- → The significance of single nucleotide polymorphism rs2070770 inCD20gene in Chinese patients with diffuse large B-cell lymphoma(2014)6 cited
- → [The Prognostic Value of Del(1p32) in Patients with Newly Diagnosed Multiple Myeloma].(2024)1 cited
- → Penpulimab in Combination with Lenalidomide and R-GemOx Regimen (R2-GemOx-PD1i) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Multicentre, Single-Arm, Phase 2 Trial(2025)
- → PharmaNews / PharmaTicker(2008)